iBio
IBIO
#10297
Rank
โ‚ฌ46.79 M
Marketcap
0,66ย โ‚ฌ
Share price
-4.00%
Change (1 day)
-29.80%
Change (1 year)

Market capitalization of iBio (IBIO)

Market cap: โ‚ฌ46.79 Million

As of November 2026 iBio has a market cap of โ‚ฌ46.79 Million. This makes iBio the world's 10297th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of iBio from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ46.79 M29.34%
2025โ‚ฌ36.17 M67.95%
2024โ‚ฌ21.54 M766.91%
2023โ‚ฌ2.48 M-33.38%
2022โ‚ฌ3.72 M-96.47%
2021โ‚ฌ0.10 B-41.55%
2020โ‚ฌ0.18 B1390.47%
2019โ‚ฌ12.12 M-2.23%
2018โ‚ฌ12.4 M-27.12%
2017โ‚ฌ17.02 M-49.13%
2016โ‚ฌ33.46 M-15.5%
2015โ‚ฌ39.6 M-2.31%
2014โ‚ฌ40.54 M159.35%
2013โ‚ฌ15.63 M-30.18%
2012โ‚ฌ22.38 M8.18%
2011โ‚ฌ20.69 M-73.02%
2010โ‚ฌ76.71 M331.96%
2009โ‚ฌ17.76 M908.06%
2008โ‚ฌ1.76 M

End of Day market cap according to different sources

On Nov 15th, 2026 the market cap of iBio was reported to be:

โ‚ฌ46.79 Million
by Nasdaq info icon info icon
โ‚ฌ46.79 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ624.39 B 1,334,245.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
โ‚ฌ0 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚ฌ1.15 B 2,373.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.27 B 477.46%๐Ÿ‡บ๐Ÿ‡ธ USA